Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication on Q4FY21 Results18-05-2021
18-05-2021
Gland Pharma Ltd - 543245 - Fixes Record Date for AGM
Gland Pharma Ltd has informed BSE that the Company has fixed August 10, 2021 as the Record Date for the purpose of 43rd Annual General Meeting (AGM) of the Company to be held on August 26, 2021.18-05-2021
Earnings Call for Q4FY21 of Gland Pharma
Conference Call with Gland Pharma Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.17-05-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Earnings Call audio- Q4FY2117-05-2021
Gland Pharma Ltd - 543245 - Outcome of Board Meeting (AGM on August 26, 2021)
Gland Pharma Ltd has informed BSE about Outcome of Board Meeting held on May 17, 2021.17-05-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Q4FY21 Financial Results17-05-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Q4FY21 Financial Results17-05-2021
Gland Pharma Ltd - 543245 - Audited Financial Results For The Quarter And Financial Year Ended March 31, 2021
The Board of Directors of Gland Pharma Limited (the 'Company') at its Meeting held today, i.e. Monday, May 17, 2021 has inter-alia considered and approved Audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 202117-05-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report dated May 12, 2021 in respect of utilization of proceeds of IPO for the quarter ended March 31, 2021 issued by M/s. Axis Bank Limited, Monitoring Agency12-05-2021